BRN Discussion Ongoing

[CHIPS]

Why do Germans sound like they are swearing, when they are excited

Do we ? That's funny because we hardly swear especially compared to the Australian, American, or British.
I guess German just sounds harder than English to foreigners.

 

[Boab]

Great Boab, I haven't seen it yet. We recently received a report from a doctor and computer scientist in Germany about how much AI will help with cancer in the future. As a radiologist, you would easily recognize a cancer cell, but a cell that is currently mutating could be recognized by AI. I am most excited about health and helping the sick.

Here is the summary if you haven't got the time to read it all

 

[IloveLamp]

Welcome to the closing of the first trading day of the year of the Dragon (which kicked off on Sat 10th), so today was the beginning of the Dragon trading year. The Dragon as some of you may know is an auspicious beast, and I see that some here have enjoyed an auspicious beginning to what very likely shapes as a breakout year for BRN.
View attachment 56657
This celestial Dragon has some whiskers, just like me, so I thought he was very appropriate particularly since myself being born in Feb 1952 makes me a hairy Dragon as well, although not celestial just yet.

Moving on from the Dragon and speaking about breakouts, today was a breakout from the trading range which BRN has been confined by since Oct 30 last year. BRN SP has 3 times been restricted by the 25c resistance level (which has now become initial support), but today BRN broke out above 25c on big volume and went as high as 27.5c intra day, which are usually important technical traits that speak to a sustainable move upwards in price trajectory. See chart below:

View attachment 56664 So this chart has the box (they are known as Darvas boxes) that has confined price action since Oct 30th up until today 12th Feb, the price range has been 15c to 25c for a duration of a lengthy 70 trading days. Resistance is at 27.5c (todays high) and two areas of low prices from late Aug and mid Sept. Also take note of the downtrend channel, you can also see in the box that price action has now finally broken above the top line of the said downtrend channel.

This is significant on a number of levels, most importantly is the fact that this trend channel has completely enveloped price action since the beginning of 2023, but not only that, this trend channel has contained most price action since early March 2022, so I am more than a little happy to see that line is no longer ruling price action - that is not saying a lot when the recent lows are considered, but it's finally going in the right direction. Also important is the fact that the upper trend line intersects exactly at the price level of the recent SP low (15c), technically speaking it was better for price action not to revisit or break the 14.5c level we saw on Oct 6th 2023. See longer term chart below:

View attachment 56665 Something that may or may not be of interest to those who struggle to understand the importance of technical analysis in the wider world of investing, my sources are a number of traders and analysts who work for brokerages, and a mate who was a well known Sydney stockbroker who is now retired. All these people regard technical analysis as important as fundamental analysis, and some traders work off technicals alone, but something my retired broker friend told me is that some of the most highly sought after people in the broking/trading game these days are known as quants (quantitative analysts) these people know technical analysis back to front, and sideways as well. The reason these quants are so highly sought after is because apart from their knowledge of technical analysis, they can also write complex code, and are they are the ones who program the algorithmic trading bots, I have followed bot trading action enough to know there is no doubt that quants employ Fibbonacci numbers and ratios, and Elliott Wave analysis.

Of course fundamental analysis is also extremely important, and my approach (and others I know) is to use fundamental and technical analysis.

Speaking of fundamentals something that made my ears stand up today were the posts by Diogenese and Fact Finder with regard to Nvidia, Diogenese had put up post #76,677 around Nvidia and a $30billion chip, Fact Finder responded with post #76,712, and it was the quote from Rob Telson that I have considered many times, and have looked here to look for further clues; RT suggested that Nvidia was more likely to be a partner than a competitor.

At this point it is still speculation, but the growing connection between BRN and the growing eco-system, and the connections between BRNs' partners in the larger tech industry eco-system, just continues to grow. BRN is growing its' reputation and the potential here now looks to be growing every day. I am excited (but at the same time very calm) about the coming of age of this investment I have made - at last.

Another great post generously constructed @McHale thanks for your efforts

 

[Diogenese]

This article is now up on the website which I hadn't seen before.
Maybe others have read it? It is under the "Blog" section.
Please enjoy

Finding Bacteria in Blood: A Hardware-based Neuromorphic Solution for Real-World E-Nose Applications

Explore the revolutionary application of neuromorphic technology in creating an electronic nose for real-world scenarios.

brainchip.com

Hi Boab,

This is almost like a blend of the earlier NaNose and Biotome developments.

NaNose was intended to detect VOC patterns in breath, This detects VOCs in the blood.

Biotome was also a blood detector.

I think that NaNose had problems with their nanotech detector, (it was withdrawn from the FDA approval process) whereas this system uses MOS/MOSFET transistors.

A lot of work was put into adapting the Örebro Uni bacteria VOC library to Akida SNN format. The Orebro model only covers 10 bacteria, so maybe more work needs to be done to build a larger model.

Apparently this was published in November 2023:

https://brainchip.com/brainchip-det...bacteria-in-the-blood-in-new-research-report/

I can't find the author's names/affiliations, but Anup Vanarse PhD (BRN, Perth) is quoted in the BRN release.

 

[Boab]

Hi Boab,

This is almost like a blend of the earlier NaNose and Biotome developments.

NaNose was intended to detect VOC patterns in breath, This detects VOCs in the blood.

Biotome was also a blood detector.

I think that NaNose had problems with their nanotech detector, (it was withdrawn from the FDA approval process) whereas this system uses MOS/MOSFET transistors.

A lot of work was put into adapting the Örebro Uni bacteria VOC library to Akida SNN format. The Orebro model only covers 10 bacteria, so maybe more work needs to be done to build a larger model.

Apparently this was published in November 2023:

https://brainchip.com/brainchip-det...bacteria-in-the-blood-in-new-research-report/

I can't find the author's names/affiliations, but Anup Vanarse PhD (BRN, Perth) is quoted in the BRN release.

Exciting times ahead.

 

[Dugnal]

It’s time to ban penny stocks from Australia’s flagship share index

The collapse of Lake Resources and poor performance of BrainChip and Imugene shows why there’s no place for penny stocks in a serious sharemarket index.

www.afr.com

I want to see this Tom Richardson cry ... the latest 2025, preferably now!
________________________________________________________________________________________________________________________

It’s time to ban penny stocks from Australia’s flagship share index​

If you want to attract and win the trust of serious overseas investors including sovereign wealth funds, pension funds, and asset managers you don’t want a flagship index pockmarked by penny stocks.

Tom Richardson Journalist
Jun 26, 2023 – 11.00am

Penny stocks are rearing their ugly heads on Australia’s flagship S&P/ASX 200 Index with alarming regularity, in a reflection of the market’s deteriorating quality, as the ASX shrinks for the first time in 18 years.
Last week, Australia’s flagship index resembled a penny stock casino, with shares in lithium explorer Lake Resources crashing 38 per cent to 29.5¢ after it revealed a six-year delay to its Argentinian lithium project. Speculative biotech Imugene finished the week at just 8.9¢, with tech hopeful BrainChip losing 13.8 per cent over the week to 34.5¢.

The benchmark S&P/ASX 200 index now has multiple stocks trading below $1 as the market shrinks for the first time in 18 years. iStock
The performance across what is supposed to be an index of blue-chip businesses is a growing problem, given passive index tracking funds mean almost every Australian has some financial interest in the success of the S&P/ASX 200.
Moreover, BrainChip, Imugene, and Lake Resources share common traits of unproven business models, virtually no revenue, heavy share selling by insiders, and penny stock prices that equal daily volatility.
All this hasn’t excluded them from benchmark membership, although other jurisdictions would have no truck with this nonsense.

RELATED QUOTES​

ASXASX Limited​

$67.160 -0.06%
1 year1 day


Updated: Feb 12, 2024 – 8.22pm. Data is 20 mins delayed.
View ASX related articles

IMUImugene Limited​

$0.110 4.76%

BRNBrainchip Holdings​

$0.260 15.56%

LKELake Resources​

$0.091 -3.19%

Poor returns​

In the US, penny stocks – defined as those that trade below $US1 – are banned for good reason. They’re viewed as ripe for manipulation. A 10¢ stock only needs 10 bids higher to 20¢ to soar 100 per cent and double a manipulator’s money.
By comparison 10 bids higher on a $20 stock to $20.10 will only add 0.5 per cent, which shows why penny stocks are attractive to those seeking to get rich quick, illicitly.

In the age of anonymous social media and online chatrooms, it’s easy for an organised group to create false hype around a business and use multiple trading accounts to sell the stock to themselves at incrementally higher prices in a bid to inflate valuations.
The hundreds of millions of dollars of easy profits on offer mean penny stocks are regularly targeted by promoters. The US regulator, the SEC, charged 16 defendants last year after it said it uncovered a multi-year fraudulent penny stock scheme that generated more than $US194 million ($290 million) in illegal profits.

Last September, The Australian Financial Review revealed Telegram pump-and-dump groups actively targeted penny stocks like Australasian Gold, which had a low number of shares on issue, relatively large amount held by top-20 shareholders, and a price-sensitive announcement in the market to evade trading halts from suspicious regulators.

There’s no suggestion Imugene has been targeted by manipulators, but it currently has a massive 6.42 billion shares on issue to equal a $571 million market cap at 8.9¢. In other words, it could add or lose a $1 billion in value with just a 16¢-share price move.
The cancer research group has no potential treatments in the Phase III clinical trial phase, but joined Standard & Poor’s’ index of Australia’s top 200 companies in December 2021 and has cratered more than 80 per cent since.
Lake Resources entered the S&P/ASX 200 Index in June 2022 and its shares have also plunged more than 80 per cent since.

As a corollary, if you want to attract and win the trust of serious overseas investors – including sovereign wealth funds, pension funds, and asset managers – you don’t want a flagship index pockmarked by penny stocks.
The UK’s regulatory environment forces around 850 smaller, speculative companies to list on its Alternative Investment Market to ringfence the integrity and attractiveness of its benchmark FTSE 100 Index. It makes sense to separate out speculative businesses from real businesses to protect investors, while still helping small companies attract capital.

Elsewhere, Australia’s rival for Asia-Pacific capital markets, Singapore, built its economy on tough financial services regulation that gave international investors confidence in its markets and a competitive advantage over dozens of regional competitors. The island state teems with international law firms, hedge funds, and asset managers precisely because sound regulation attracts capital and brings jobs.

Today, a business can list on the ASX with a minimum market cap of just $15 million, with inclusion in the S&P/ASX 200 based on minimum free floats, market cap, and trading volumes.
As a starting point, the S&P/ASX 200 should exclude businesses that have zero revenue and stock prices under $1 to protect index buyers and other market participants.

Once apon a time the AFR was a trusted paper..

 

[Sirod69]

Hallo Boab,

Dies ist fast wie eine Mischung aus den früheren Entwicklungen von NaNose und Biotome.

NaNose sollte VOC-Muster im Atem erkennen. Dadurch werden VOCs im Blut erkannt.

Biotome war auch ein Blutdetektor.

Ich glaube, dass NaNose Probleme mit ihrem Nanotech-Detektor hatte (er wurde aus dem FDA-Zulassungsverfahren zurückgezogen), während dieses System MOS/MOSFET-Transistoren verwendet.

Es wurde viel Arbeit in die Anpassung der Bakterien-VOC-Bibliothek der Örebro Uni an das Akida-SNN-Format gesteckt. Das Orebro-Modell deckt nur 10 Bakterien ab, daher muss möglicherweise mehr Arbeit geleistet werden, um ein größeres Modell zu erstellen.

Offenbar wurde dies im November 2023 veröffentlicht:

https://brainchip.com/brainchip-det...bacteria-in-the-blood-in-new-research-report/

Ich kann die Namen/Zugehörigkeiten des Autors nicht finden, aber Anup Vanarse PhD (BRN, Perth) wird in der BRN-Pressemitteilung zitiert.

We all probably didn't have it on our radar, i.e. a piece of paper, or forgot it. But we shouldn't care about that now, right?

PDF:
:

 

[Diogenese]

We all probably didn't have it on our radar, i.e. a piece of paper, or forgot it. But we shouldn't care about that now, right?

PDF:
: View attachment 56672

Yep - it's anonymous too.

 

[Esq.111]

Good Morning Chippers ,

Looks like ARM has opened with a little vigor... BOOM.

Arm Holdings ADR Share Price | NASDAQ ARM Stock - Investing.com AU

View the real-time Arm Holdings ADR (NASDAQ ARM) share price. Assess historical data, charts, technical analysis and contribute in the forum.

au.investing.com

Regards,
Esq.

 

[charles2]

What a difference a day makes:

BMR to collaborate with NVDA....up 981%

Beamr Imaging Ltd. (BMR)​

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow

22.82+20.71(+981.41%)
As of 11:18AM EST. Market open.

• Summary
• Chart
• Conversations
• Statistics
• Historical Data
• Profile
• Financials
• Analysis
• Options
• Holders
• Sustainability
• 1D
• 5D
• 1M
• 6M
• YTD
• 1Y
• 5Y
• Max

Full screen

Trade prices are not sourced from all markets

Previous Close	2.11
Open	6.07
Bid	17.64 x 1800
Ask	17.71 x 2200
Day's Range	6.06 - 23.00
52 Week Range	0.91 - 23.00
Volume	94,298,406
Avg. Volume	148,767

Market Cap	294.567M
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	-0.10
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	5.00

MAYBE TIME TO COLLABORATE?

 

[Tothemoon24]

​

​

New UN regulation paves the way for the roll-out of additional driver assistance systems​

Autonomous DrivingVehicle RegulationsRoad Safety
Sustainable DevelopmentTransport

01 February 2024

UNECE’s Working Party on Automated/Autonomous and Connected Vehicles has adopted the draft of a new regulation that defines provisions for the approval of vehicles with Driver Control Assistance Systems (DCAS) and provides minimum safety requirements for vehicles equipped with the Advanced Driver Assistance System (ADAS), such as lane keep assist.
DCAS are a subset of Advanced Driver Assistance Systems (ADAS). While active, DCAS are able to stabilize or manoeuvre the vehicle.
The new regulation builds on UN Regulation No. 79adopted in 2018 and covers a broader range of technologies to be introduced in new models. For instance, the new regulation will no longer limit the use of lane changing systems to motorways (roads with 2 lanes and a physical separation from traffic in the opposite direction) but will extend it to other types of roads.
The new regulation aims to allow the approval of a combination of driving control assistance features, including assistance to braking, accelerating, and overtaking.
However, the new regulation does not cover full driving automation, and therefore requires manufacturers to implement strategies to ensure that drivers have appropriate knowledge of the capabilities of assistance systems and do not overestimate them (mode awareness).
To avoid driver overreliance on such systems, the regulation stipulates that DCAS shall be designed to ensure that the driver remains engaged with the driving task. The driver’s hands must remain on the wheel and the system shall monitor the driver’s visual engagement with the road, triggering alarms after 5 seconds when it detects that this is no longer the case.
The regulation also stipulates that manufacturers will be required to submit an outline of the systems’ design to type approval authorities. The validation of DCAS shall ensure that a thorough assessment, considering the functional and operational safety of the features integrated in DCAS and the entire DCAS integrated into a vehicle, is performed by the manufacturer during the design and development processes.
The regulation will require manufacturers to monitor the performance of these systems once on the roads and provide periodic (at least once a year) and ad-hoc reports on critical safety occurrences to the authority that approved the vehicle.
The new regulation will be submitted to the World Forum for Harmonization of Vehicle Regulations (WP.29) for adoption in June 2024, with an entry into force foreseen in January 2025.

 

[cosors]

Let all shorters burn and give control back to healthy money-making and growth.

Until now... Wait and see the coming days: Arm’s stock surge burns short sellers, to the tune of $445 million in paper losses

until now here:

 

[Esq.111]

Morning Charles2 ,

Thay are having a good run indeed .

Beamr Imaging Ltd (BMR) Stock Price & News - Google Finance

Get the latest Beamr Imaging Ltd (BMR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

g.co

Regards,
Esq

 

[cosors]

Once apon a time the AFR was a trusted paper..

I find the statement absurd that someone sets a threshold and only above this is a company entitled to be included in the 200 if it still has a low turnover. And this absurdly completely ignores the position the company occupies or the patents it holds.
To illustrate my thought, imagine ARM were to spin off all its patents into a new company and go public on the ASX. The 200 would be denied until some other defined threshold for reasonable turnover is exceeded?! Absurd that is.

 

[DingoBorat]

Let all shorters burn and give control back to healthy money-making and growth.
View attachment 56674

until now here:
View attachment 56675

That's what I'm talking about baby!

Some decent volume, on the German exchanges!

 

[cosors]

That's what I'm talking about baby!

Some decent volume, on the German exchanges!


View attachment 56678

I know, I know. Probably ridiculous for you and a ⅒th (?) of your volume. But that's neat here. It was almost dusty here on the exchanges. All the exchanges need to be added up...

 

[Esq.111]

Chippers ,

Shaping up very nicely for today ,

Start the day with a bang....



Regards,
Esq.

 

[DingoBorat]

I find the statement absurd that someone sets a threshold and only above this is a company entitled to be included in the 200 if it still has a low turnover. And this absurdly completely ignores the position the company occupies or the patents it holds.
To illustrate my thought, imagine ARM were to spin off all its patents into a new company and go public on the ASX. The 200 would be denied until some other defined threshold for reasonable turnover is exceeded?! Absurd that is.

I have to disagree with you here Corsors.

As FactFinder said..
"Shorting should be banned fullstop but at the very least pre revenue companies should be protected"

Pre-revenue companies, have a "natural" protection from shorters, if not included in the ASX300 or ASX200, because the shares to lend to them, are just not available in large quantities.

This is the Time and opportunity, for them, to raise funds, while they are still pre-revenue.

If their market capitalisation, forces them into the Big Boys Club (ASX300/200) this period of protection disappears and it's open slather, for the wolves to prey on the young "defenseless" lambs..

The author's original "complaint" was about the "quality" of the index, but I can see, how a young company, would want to avoid inclusion, until it was "ready" had building revenue and was profitable.

Just my opinions and happy to differ..

 

[cosors]

I have to disagree with you here Corsors.

As FactFinder said..
"Shorting should be banned fullstop but at the very least pre revenue companies should be protected"

Pre-revenue companies, have a "natural" protection from shorters, if not included in the ASX300 or ASX200, because the shares to lend to them, are just not available in large quantities.

This is the Time and opportunity, for them, to raise funds, while they are still pre-revenue.

If their market capitalisation, forces them into the Big Boys Club (ASX300/200) this period of protection disappears and it's open slather, for the wolves to prey on the young "defenseless" lambs..

The author's original "complaint" was about the "quality" of the index, but I can see, how a young company, would want to avoid inclusion, until it was "ready" had building revenue and was profitable.

Just my opinions and happy to differ..

I was able to understand the article at from the beginning I think. And I have no problem with divergent opinions at all! It makes things clearer. I'm concerned with these two threshold values that need to be defined. And that raises the question and doubt in my mind - who sets them and by what standard/interest? In my view, the value of a company is not defined solely by turnover.
Quite apart from the fact that too little is said about profit.
So this exclusive club should only be for companies that fulfil these two thresholds, thus further cementing the model of this exclusive society?
I fully agree that it was too early for BRN. However, this is not because of the value that lies dormant in this company, but because of the existing system. I was very surprised that Brainchip was repeatedly denied an exit. My naive thought, and I really don't know much about such things, is why BRN wasn't downgraded when it was the time to.)

___
I simply don't trust this system and don't think it is conducive to healthy growth. Investment in the future is not just debt. A discussion that is very topical here in Germany in these days.

___
Regarding the second threshold: no turnover? That was and is not correct. Bad journalism. So how much turnover is appropriate for the 200. Maybe that explains one of my concerns.

 

[Pom down under]

Chippers ,

Shaping up very nicely for today ,

Start the day with a bang....



Regards,
Esq.